JP2015516451A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015516451A5 JP2015516451A5 JP2015511957A JP2015511957A JP2015516451A5 JP 2015516451 A5 JP2015516451 A5 JP 2015516451A5 JP 2015511957 A JP2015511957 A JP 2015511957A JP 2015511957 A JP2015511957 A JP 2015511957A JP 2015516451 A5 JP2015516451 A5 JP 2015516451A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- pharmaceutical dosage
- weeks
- hours
- refers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000002193 Pain Diseases 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 5
- 208000005298 acute pain Diseases 0.000 description 2
- 239000002831 pharmacologic agent Substances 0.000 description 2
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12003895 | 2012-05-18 | ||
| EP12003895.5 | 2012-05-18 | ||
| PCT/EP2013/001470 WO2013170971A1 (en) | 2012-05-18 | 2013-05-16 | Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and a nsar |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015516451A JP2015516451A (ja) | 2015-06-11 |
| JP2015516451A5 true JP2015516451A5 (enExample) | 2017-03-09 |
| JP6116678B2 JP6116678B2 (ja) | 2017-04-19 |
Family
ID=48520892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015511957A Active JP6116678B2 (ja) | 2012-05-18 | 2013-05-16 | （１ｒ，４ｒ）−６’−フルオロ−Ｎ，Ｎ−ジメチル−４−フェニル−４’，９’−ジヒドロ−３’Ｈ−スピロ［シクロヘキサン−１，１’−ピラノ［３，４，ｂ］インドール］−４−アミンおよびＮＳＡＲを含む医薬組成物 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8912226B2 (enExample) |
| EP (1) | EP2849747B1 (enExample) |
| JP (1) | JP6116678B2 (enExample) |
| CN (1) | CN104284660A (enExample) |
| AU (1) | AU2013262077B2 (enExample) |
| BR (1) | BR112014028566A2 (enExample) |
| CA (1) | CA2873867A1 (enExample) |
| CY (1) | CY1119781T1 (enExample) |
| DK (1) | DK2849747T3 (enExample) |
| EA (1) | EA027145B1 (enExample) |
| ES (1) | ES2658217T3 (enExample) |
| HR (1) | HRP20171725T1 (enExample) |
| HU (1) | HUE034658T2 (enExample) |
| IL (1) | IL235653B (enExample) |
| LT (1) | LT2849747T (enExample) |
| MX (1) | MX356493B (enExample) |
| NO (1) | NO2849747T3 (enExample) |
| PL (1) | PL2849747T3 (enExample) |
| PT (1) | PT2849747T (enExample) |
| RS (1) | RS56788B1 (enExample) |
| SI (1) | SI2849747T1 (enExample) |
| WO (1) | WO2013170971A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6673924B2 (ja) | 2015-01-23 | 2020-03-25 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 肝機能障害および／または腎機能障害を有する対象における疼痛を治療するためのセブラノパドール |
| WO2016168388A2 (en) | 2015-04-14 | 2016-10-20 | Palatin Technologies, Inc. | Therapies for obesity, diabetes and related indications |
| WO2017148595A1 (en) | 2016-02-29 | 2017-09-08 | Grünenthal GmbH | Titration of cebranopadol |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0068838B1 (en) | 1981-06-26 | 1986-09-17 | The Upjohn Company | Analgesic process and composition |
| US4389393A (en) | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4404208A (en) * | 1982-06-30 | 1983-09-13 | E. I. Du Pont De Nemours And Company | Analgesic mixture of nalbuphine and tiflamizole |
| US4612008A (en) | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
| US4783337A (en) | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
| US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| CA2058754C (en) | 1989-05-22 | 2002-02-19 | Hubertus L. Regtop | Divalent metal salts of indomethacin |
| US5472711A (en) | 1992-07-30 | 1995-12-05 | Edward Mendell Co., Inc. | Agglomerated hydrophilic complexes with multi-phasic release characteristics |
| US5330761A (en) | 1993-01-29 | 1994-07-19 | Edward Mendell Co. Inc. | Bioadhesive tablet for non-systemic use products |
| US5455046A (en) | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
| US5399362A (en) | 1994-04-25 | 1995-03-21 | Edward Mendell Co., Inc. | Once-a-day metoprolol oral dosage form |
| US5914129A (en) | 1996-07-23 | 1999-06-22 | Mauskop; Alexander | Analgesic composition for treatment of migraine headaches |
| ATE279920T1 (de) | 2000-12-28 | 2004-11-15 | Fresenius Kabi Austria Gmbh | Stabile infusionslösung von diclofenac-salzen, deren herstellung und verwendung |
| ATE359827T1 (de) | 2002-06-17 | 2007-05-15 | Chiesi Farma Spa | Prozess für die vorbereitung von piroxicam: beta- cyclodextrin einschlusskomplexe |
| DE10252667A1 (de) | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DE10257824B4 (de) | 2002-12-10 | 2004-11-11 | Kochem, Hans-Günter, Dr. | Zusammensetzung zur Schmerzbehandlung, insbesondere zur Behandlung von Gelenkschmerzen |
| US20100297252A1 (en) | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
| US7132452B2 (en) | 2003-03-10 | 2006-11-07 | Fang-Yu Lee | Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection |
| DE10360792A1 (de) | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| MX2007016217A (es) * | 2005-06-17 | 2008-03-07 | Pfizer | Compuestos de alfa-(aril- o heteroaril-metil)-beta-piperidinopropa namida como antagonista del receptor orl1. |
| HRP20110271T1 (hr) * | 2006-04-28 | 2011-05-31 | Grnenthal Gmbh | Farmaceutska kombinacija koja sadrži 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i nsaid (nesteroidni antiinflamatorni lijek) |
| CN101147735A (zh) | 2006-09-19 | 2008-03-26 | 沈阳华泰药物研究有限公司 | 注射用药物组合物及其药盒 |
| DE102006046745A1 (de) | 2006-09-29 | 2008-04-03 | Grünenthal GmbH | Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz |
| DE102006056458A1 (de) | 2006-11-28 | 2008-05-29 | Grünenthal GmbH | Arzneimittelzubereitung von Tramadol und Acetaminophen |
| EP2207569B1 (en) * | 2007-10-09 | 2013-03-27 | Merck Patent GmbH | Pharmaceutical compositions containing benfotiamine and one or more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin |
| CN100560061C (zh) | 2008-06-20 | 2009-11-18 | 海南锦瑞制药股份有限公司 | 一种氯诺昔康冻干粉针剂及其制备方法 |
| KR101730924B1 (ko) * | 2008-09-05 | 2017-04-27 | 그뤼넨탈 게엠베하 | 3-（3-디메틸아미노-1-에틸-2-메틸-프로필）-페놀과 항간질제의 약제학적 병용물 |
| MX2011002117A (es) * | 2008-09-05 | 2011-03-28 | Gruenenthal Gmbh | Combinacion farmaceutica que comprenden 6-dimetilaminometil-1-(3-m etoxi-fenil)-ciclohexano-1,3-diol y un aines. |
| ES2553742T3 (es) * | 2010-08-04 | 2015-12-11 | Grünenthal GmbH | Forma de dosificación farmacéutica que comprende 6'-fluor-(N-metil- o N,N-dimetil)-4-fenil-4',9'-dihidro-3'H-espiro[ciclohexano-1,1'-pirano[3,4,b]indol]-4-amina |
| HRP20180904T1 (hr) * | 2010-08-04 | 2018-08-24 | Grünenthal GmbH | Farmaceutski oblik doziranja koji sadrži 6'-fluoro-(n-metil-ili n,n-dimetil-)-4-fenil-4',9'-dihidro-3'h-spiro[cikloheksan-1,1'-pirano[3,4,b]indol]-4-amin za liječenje neuropatske boli |
| PL2600846T3 (pl) * | 2010-08-04 | 2016-05-31 | Gruenenthal Gmbh | Farmaceutyczna postać dawki zawierająca 6'-fluoro-(n-metylo- albo N,N-dimetylo-)-4-fenylo-4',9'-dihydro-3'H-spiro[cykloheksano-1,1'-pirano[3,4,b]indol]-4-aminę |
-
2013
- 2013-05-13 US US13/892,732 patent/US8912226B2/en active Active
- 2013-05-16 HR HRP20171725TT patent/HRP20171725T1/hr unknown
- 2013-05-16 PL PL13725072T patent/PL2849747T3/pl unknown
- 2013-05-16 NO NO13725072A patent/NO2849747T3/no unknown
- 2013-05-16 CA CA2873867A patent/CA2873867A1/en not_active Abandoned
- 2013-05-16 CN CN201380025645.4A patent/CN104284660A/zh active Pending
- 2013-05-16 RS RS20180063A patent/RS56788B1/sr unknown
- 2013-05-16 DK DK13725072.6T patent/DK2849747T3/en active
- 2013-05-16 EP EP13725072.6A patent/EP2849747B1/en not_active Not-in-force
- 2013-05-16 BR BR112014028566A patent/BR112014028566A2/pt active Search and Examination
- 2013-05-16 PT PT137250726T patent/PT2849747T/pt unknown
- 2013-05-16 MX MX2014013028A patent/MX356493B/es active IP Right Grant
- 2013-05-16 EA EA201401270A patent/EA027145B1/ru not_active IP Right Cessation
- 2013-05-16 SI SI201330926T patent/SI2849747T1/en unknown
- 2013-05-16 WO PCT/EP2013/001470 patent/WO2013170971A1/en not_active Ceased
- 2013-05-16 JP JP2015511957A patent/JP6116678B2/ja active Active
- 2013-05-16 HU HUE13725072A patent/HUE034658T2/hu unknown
- 2013-05-16 ES ES13725072.6T patent/ES2658217T3/es active Active
- 2013-05-16 LT LTEP13725072.6T patent/LT2849747T/lt unknown
- 2013-05-16 AU AU2013262077A patent/AU2013262077B2/en not_active Ceased
-
2014
- 2014-11-12 IL IL235653A patent/IL235653B/en active IP Right Grant
-
2018
- 2018-01-16 CY CY20181100051T patent/CY1119781T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20200600T1 (hr) | Tapentadol za sprječavanje i liječenje depresije i tjeskobe | |
| JP2015057451A5 (enExample) | ||
| JP2016053040A5 (enExample) | ||
| JP2012193216A5 (enExample) | ||
| FI3562486T3 (fi) | Kielenalaisen deksmedetomidiinin käyttö agitaation hoidossa | |
| JP2015523407A5 (enExample) | ||
| JP2013155188A5 (enExample) | ||
| JP2015517488A5 (enExample) | ||
| HRP20211543T1 (hr) | Derivati kinazolina koji se koriste za liječenje hiv-a | |
| MX383665B (es) | Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer. | |
| EP4609912A3 (en) | New use of a combination of sacubitril and valsartan | |
| JP2013231087A5 (enExample) | ||
| HRP20250615T1 (hr) | Tradipitant za upotrebu u liječenju gastropareze | |
| RU2017116740A (ru) | Комбинации для лечения рассеянного склероза | |
| JP2017512194A5 (enExample) | ||
| JP2017507142A5 (enExample) | ||
| WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
| CA3010568A1 (en) | Oromucosal nanofiber carriers for therapeutic treatment | |
| JP2019529570A5 (enExample) | ||
| JP2020529995A5 (enExample) | ||
| HRP20241716T1 (hr) | Postupci liječenja promjena u ponašanju | |
| JP2015516452A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| JP2019507786A5 (enExample) | ||
| JP2015516450A5 (enExample) |